ARTICLE | Clinical News
MelVax therapeutic vaccine: Began a multi-center Phase Ib/IIa trial
September 20, 1993 7:00 AM UTC
ImClone Systems Inc. (IMCL) Product: MelVax therapeutic vaccine, anti-idiotypic monoclonal antibody designed to mimic GD3, an antigen that is found on the surface of melanoma tumor cells Indication: T...